2014
Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study.
Xicola RM, Gagnon M, Clark JR, Carroll T, Gao W, Fernandez C, Mijic D, Rawson JB, Janoski A, Pusatcioglu CK, et al. 2014. Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study. Clin Cancer Res. 20:4962–70. doi:10.1158/1078-0432.CCR-14-0353.
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.
Gruessner C, Gruessner A, Glaser K, AbuShahin N, Zhou Y, Laughren C, Wright H, Pinkerton S, Yi X, Stoffer J, et al. 2014. Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence. Cancer Prev Res (Phila). 7:896–905. doi:10.1158/1940-6207.CAPR-13-0408.
Myocardial ischemic reperfusion induces de novo Nrf2 protein translation.
Xu B, Zhang J, Strom J, Lee S, Chen QM. 2014. Myocardial ischemic reperfusion induces de novo Nrf2 protein translation. Biochim Biophys Acta. 1842:1638–47. doi:10.1016/j.bbadis.2014.06.002.
A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones.
Chow H-HS, Garland LL, Heckman-Stoddard BM, Hsu C-H, Butler VD, Cordova CA, Chew WM, Cornelison TL. 2014. A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. J Transl Med. 12:223. doi:10.1186/s12967-014-0223-0.
Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD.
Zeng Y, Stokes J, Hahn S, Hoffman E, Katsanis E. 2014. Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD. Bone Marrow Transplant. 49:1076–83. doi:10.1038/bmt.2014.91.
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors.
Mahalingam D, Mita M, Sarantopoulos J, Wood L, Amaravadi RK, Davis LE, Mita AC, Curiel TJ, Espitia CM, Nawrocki ST, et al. 2014. Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy. 10:1403–14. doi:10.4161/auto.29231.
Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease.
Sivendran S, Chang R, Pham L, Phelps RG, Harcharik ST, Hall LD, Bernardo SG, Moskalenko MM, Sivendran M, Fu Y, et al. 2014. Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease. J Invest Dermatol. 134:2202–2211. doi:10.1038/jid.2014.85.
Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans.
Hester AG, Murphy RC, Uhlson CJ, Ivester P, Lee TC, Sergeant S, Miller LR, Howard TD, Mathias RA, Chilton FH. 2014. Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans. J Biol Chem. 289:22482–9. doi:10.1074/jbc.M114.579557.
Ubiquitin-specific peptidase 20 regulates Rad17 stability, checkpoint kinase 1 phosphorylation and DNA repair by homologous recombination.
Shanmugam I, Abbas M, Ayoub F, Mirabal S, Bsaili M, Caulder EK, Weinstock DM, Tomkinson AE, Hromas R, Shaheen M. 2014. Ubiquitin-specific peptidase 20 regulates Rad17 stability, checkpoint kinase 1 phosphorylation and DNA repair by homologous recombination. J Biol Chem. 289:22739–48. doi:10.1074/jbc.M114.550459.
Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling.
Kumar S, Pan CC, Bloodworth JC, Nixon AB, Theuer C, Hoyt DG, Lee NY. 2014. Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling. Oncogene. 33:3970–9. doi:10.1038/onc.2013.386.
F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.
Hockenberry MJ, Taylor OA, Gundy PM, Ross AK, Pasvogel A, Montgomery D, Ribbeck P, McCarthy K, Moore I. 2014. F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia. Biol Res Nurs. 16:303–9. doi:10.1177/1099800413498507.
Targeting the disordered C terminus of PTP1B with an allosteric inhibitor.
Krishnan N, Koveal D, Miller DH, Xue B, Akshinthala SD, Kragelj J, Jensen MR, Gauss C-M, Page R, Blackledge M, et al. 2014. Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat Chem Biol. 10:558–66. doi:10.1038/nchembio.1528.
The role of radiation therapy after nipple-sparing mastectomy.
Gomez C, Shah C, McCloskey S, Foster N, Vicini F. 2014. The role of radiation therapy after nipple-sparing mastectomy. Ann Surg Oncol. 21:2237–44. doi:10.1245/s10434-013-3446-z.
Bone cancer pain: from mechanism to therapy.
Mantyh PW. 2014. Bone cancer pain: from mechanism to therapy. Curr Opin Support Palliat Care. 8:83–90. doi:10.1097/SPC.0000000000000048.
Modelling mammalian cellular quiescence.
Yao G. 2014. Modelling mammalian cellular quiescence. Interface Focus. 4:20130074. doi:10.1098/rsfs.2013.0074.
Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases.
Chilton FH, Murphy RC, Wilson BA, Sergeant S, Ainsworth H, Seeds MC, Mathias RA. 2014. Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases. Nutrients. 6:1993–2022. doi:10.3390/nu6051993.
Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy.
Smith AK, Conneely KN, Pace TWW, Mister D, Felger JC, Kilaru V, Akel MJ, Vertino PM, Miller AH, Torres MA. 2014. Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy. Brain Behav Immun. 38:227–36. doi:10.1016/j.bbi.2014.02.010.
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.
Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WPD, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, et al. 2014. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet. 46:427–9. doi:10.1038/ng.2928.
The role of the human psoralen 4 (hPso4) protein complex in replication stress and homologous recombination.
Abbas M, Shanmugam I, Bsaili M, Hromas R, Shaheen M. 2014. The role of the human psoralen 4 (hPso4) protein complex in replication stress and homologous recombination. J Biol Chem. 289:14009–19. doi:10.1074/jbc.M113.520056.
Cancer patient perceptions about biobanking and preferred timing of consent.
Braun KL, Tsark JU, Powers A, Croom K, Kim R, Gachupin FC, Morris P. 2014. Cancer patient perceptions about biobanking and preferred timing of consent. Biopreserv Biobank. 12:106–12. doi:10.1089/bio.2013.0083.
MEK1/2 inhibitors in the treatment of gynecologic malignancies.
Miller CR, Oliver KE, Farley JH. 2014. MEK1/2 inhibitors in the treatment of gynecologic malignancies. Gynecol Oncol. 133:128–37. doi:10.1016/j.ygyno.2014.01.008.
A microfluidic model for organ-specific extravasation of circulating tumor cells.
Riahi R, Yang YL, Kim H, Jiang L, Wong PK, Zohar Y. 2014. A microfluidic model for organ-specific extravasation of circulating tumor cells. Biomicrofluidics. 8:024103. doi:10.1063/1.4868301.
Appropriate use of complementary and alternative medicine approaches in gynecologic cancers.
Chase DM, Gibson SJ, Sumner DA, Bea JW, Alberts DS. 2014. Appropriate use of complementary and alternative medicine approaches in gynecologic cancers. Curr Treat Options Oncol. 15:14–26. doi:10.1007/s11864-013-0269-x.
Beliefs regarding mammography screening among women visiting the emergency department for nonurgent care.
Hatcher-Keller J, Rayens MK, Dignan M, Schoenberg N, Allison P. 2014. Beliefs regarding mammography screening among women visiting the emergency department for nonurgent care. J Emerg Nurs. 40:e27–35. doi:10.1016/j.jen.2013.01.015.
Isolation of viable cancer cells in antibody-functionalized microfluidic devices.
Zheng X, Jiang L, Schroeder J, Stopeck A, Zohar Y. 2014. Isolation of viable cancer cells in antibody-functionalized microfluidic devices. Biomicrofluidics. 8:024119. doi:10.1063/1.4873956.